Aspirin in the prevention of cardiovascular disease in women [1] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 26, 2005, Pages 2751-2752

  Schwartz, Daniel J ^a   Dalen, James E ^b   Ridker, Paul M ^c   Buring, Julie E ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECT; GASTROINTESTINAL HEMORRHAGE; GENDER; HEART INFARCTION; HEART PROTECTION; HUMAN; LETTER; PEPTIC ULCER; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; CEREBROVASCULAR ACCIDENT; FEMALE; MALE; NOTE; CORONARY ARTERY DISEASE; RISK;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; CORONARY DISEASE; RISK;

EID: 21244495335     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200506303522617     Document Type: Letter

References (0)